Olivia Schaffer

Ms. Olivia Schaffer

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2026 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KMKyle L. McCormick
Kyle L. McCormick
OSOlivia Schaffer
Olivia Schaffer
DNDavid Novikov
David Novikov
JRJoshua C Rozell
Joshua C Rozell

15 July 2026 in Bulletin of the Hospital for Joint Diseases
Verified
Journal Article
Open access
OSOlivia Schaffer
Olivia Schaffer
BSBraden V. Saba
Braden V. Saba
BSBryce A. Saba
Bryce A. Saba
ACAnna Cohen-Rosenblum
Anna Cohen-Rosenblum
RSRan Schwarzkopf
Ran Schwarzkopf
DADiren Arsoy
Diren Arsoy
Introduction: Sarcopenia, the loss of muscle mass and function, is closely linked to poor health and has been associated with inferior outcomes in total hip arthroplasty (THA). Psoas Muscle Index (PMI) is a radiographic metric inversely correlated with sarcopenia. It was hypothesized that low PMI patients would have worse outcomes following THA. Methods: A retrospective review of 515 patients who underwent robotic primary THA between 2014 and 2022 at a single, urban, academic health system with 2-year follow-up data was performed. Psoas Muscle Index was calculated from preoperative computed tomography imaging of the pelvis. Patient baseline demographics, laboratory values, perioperative data, and outcomes were collected from chart review. Results: Low PMI occurred in 56 (10.8%) of 515 patients. There were no differences in readmissions or reoperations ( P = 0.51; P = 0.58). Low PMI was associated with higher HOOS, JR score at 2 weeks and greater improvement from baseline ( P = 0.034; P = 0.037), as well as lower Patient-Reported Outcomes Measurement Information System Pain Intensity at 3 months and greater reductions from baseline ( P = 0.038; P = 0.013). Conclusion: Psoas Muscle Index did not reliably predict surgical outcomes following THA, and low PMI was associated with better patient-reported outcome measures after surgery. Further investigation into other means of diagnosing sarcopenia may be warranted.

14 May 2026 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
OSOlivia Schaffer
Olivia Schaffer
GRGeorge A. Rublev
George A. Rublev
APArthur Perry
Arthur Perry
RRRoy Romem
Roy Romem
VAVinay K. Aggarwal
Vinay K. Aggarwal
ACAnna R. Cohen-Rosenblum
Anna R. Cohen-Rosenblum

11 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
LBLaith Bahlouli
Laith Bahlouli
OSOlivia Schaffer
Olivia Schaffer
JSJacob Stoebner
Jacob Stoebner
ACAnna Cohen-Rosenblum
Anna Cohen-Rosenblum
VAVinay K Aggarwal
Vinay K Aggarwal
RSRan Schwarzkopf
Ran Schwarzkopf
Background and Objectives: Collared, triple-tapered femoral stems have gained increasing popularity in primary total hip arthroplasty (THA) due to their stable metaphyseal fixation and ability to restore native hip biomechanics. This study evaluated the short-term clinical and functional outcomes of a novel collared triple-tapered femoral stem design in primary THA. Materials and Methods: This was a retrospective review of all patients who underwent primary, elective THA using a collared, triple-tapered femoral system at a single, urban, high-volume, academic hospital between September 2024 and February 2025. All procedures were performed by fellowship-trained arthroplasty surgeons. A total of 101 patients (102 hips) with a median follow-up of 1.1 years (range, 1.0 to 1.4 years) were included. Results: Most procedures were performed for primary osteoarthritis (96%). Mean operative time, from skin incision to skin closure, was 93 min, and most femoral stems implanted had a high offset (89%). Most patients were discharged home (96%), with a mean length of stay of 27 h. Within 90 days, three patients were readmitted for surgery-related reasons: one for superficial wound dehiscence, and two for periprosthetic joint infection (PJI). One PJI was treated with irrigation and debridement, antibiotics, and implant retention (DAIR) two months after primary THA. The other required a DAIR three weeks after primary THA, followed by a single-stage revision one week later. No dislocations, periprosthetic fractures, mechanical failures, or aseptic revisions of the femoral stem occurred. All stems were well-fixed at the latest follow-up, with no aseptic loosening observed. Mean Hip disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) improvement was 15.0 points at six weeks, 25.2 points at three months, and 45.3 points at one year. Conclusions: Our results support encouraging early outcomes with no femoral aseptic complications observed using this novel collared, triple-tapered femoral system. A longer follow-up period is needed to assess mid- and long-term durability.

5 October 2026 in Medicina
Verified
Journal Article
Open access
PDF file
OSOlivia Schaffer
Olivia Schaffer
MKMitchell Francis Kennedy
Mitchell Francis Kennedy
ALAndrew Li
Andrew Li
DNDavid Novikov
David Novikov
MMMorteza Meftah
Morteza Meftah
RSRan Schwarzkopf
Ran Schwarzkopf
Background and Objectives: Cementless total knee arthroplasty (TKA) has gained popularity but comparative outcome data across implant systems remain limited. This study compared survivorship and clinical outcomes of two cementless cruciate-retaining TKA implants from different manufacturers. Materials and Methods: We performed a retrospective, single-institution review of 220 patients who had a cementless cruciate-retaining TKA implant between 2019 and 2024; 110 patients received Implant A and 110 patients received Implant B. Baseline variables included demographics, comorbidities, and preoperative Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR). Clinical outcomes included 90-day readmission, all-time revision, reoperation, manipulation under anesthesia, and postoperative KOOS, JR scores. Propensity score-based overlap weighting was used to create a balanced pseudo-population for adjusted analyses. Adjusted outcomes included weighted logistic regression for two-year revision and a weighted Cox proportional hazards model for time to revision. Results: Crude revision rates were low and not significantly different (A: 0.9 versus B: 2.7%, p = 0.622). Overlap weighting achieved balance across all measured baseline covariates. Unadjusted rates of 90-day readmission, reoperation, and manipulation under anesthesia were similar between groups. In adjusted analyses, no statistically significant difference was observed for two-year revision in Implant B vs. A cohorts (OR 2.17, 95% CI 0.10 to 157, p = 0.621) or time to revision (HR 2.22, 95% CI 0.18 to 27.09, p = 0.533). Conclusions: Both cementless cruciate-retaining TKA systems demonstrated low early revision rates in this cohort. Propensity score-adjusted analyses reduced measured baseline imbalances and did not identify a significant difference in revision risk between implants; however, interpretation is limited by sparse revision events, potential residual confounding, and the retrospective observational design.